Clinical Trial Update: Myrosinase Bioactivated Gglucoraphanin for the Treatment of Neurodegenerative Diseases (GRA-MYR-ND) [NA]

View source ↗

Summary

This clinical trial update indicates that a study of myrosinase-activated glucoraphanin for neurodegenerative diseases is currently recruiting. The conditions l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Parkinson Disease

Drugs mentioned

• Glucoraphanin (myrosinase-activated) (glucoraphanin)

Snippet

Sponsor: IRCCS Centro Neurolesi Bonino Pulejo | Conditions: PARKINSON DISEASE (Disorder), Multiple Sclerosis (MS) - Relapsing-remitting | NA | Status: RECRUITING